Neurology Minute
American Academy of Neurology 1 937 episodes Nov 9, 2026
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Facial Pain Series - Part 1
In part one of this series, Dr. Derek Stitt discusses trigeminal neuralgia and, more specifically, how to make sure that's actually the diagnosis.
October 26, 2026 Capitol Hill Report: Conrad 30
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from October 26th, discussing international medical graduates, the Conrad 30 program, and the AAN's efforts to strengthen visa pathways for physicians serving communities across the US. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Youth Football and the Epidemic of Pediatric Brain Injury - Part 2
In part two of this series, Dr. Dara Albert and Isaac Thorman discuss guidance for parents weighing whether to let their children play tackle football. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:10.1212/CPJ.
Youth Football and the Epidemic of Pediatric Brain Injury - Part 1
In part one of this series, Dr. Dara Albert and Isaac Thorman discuss football as a major contributor to pediatric traumatic brain injury and its association with subsequent head injuries. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract.
Acute Optic Neuropathy in Older Adults
Dr. Justin Abbatemarco discusses an article that helps us distinguish between the causes of acute optic neuropathy. Show citation: Tisavipat N, Stiebel-Kalish H, Palevski D, et al. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024;11(3):e200214. doi:10.1212/NXI.000000000
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis
Dr. Aaron Zelikovich discusses how gefurulimab may offer an effective and convenient treatment option for adults with generalized myasthenia gravis. Show citation: Gwathmey KG, Saccà F, Howard JF Jr, et al. Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. JAMA Neurol. 2026;83(9):841-850. doi:10.1001/jamaneurol.2026.2333
Trends in Emergent Interfacility Ischemic Stroke Transfers
Dr. Andy Southerland and Dr. Matthew Gusler discuss how emergent interfacility transfers for ischemic stroke have changed and the factors associated with which patients are transferred. Show citation: Gusler MT, Deligkaris C, Zha AM, Burke JF. Trends in Emergent Interfacility Ischemic Stroke Transfers, 2016-2022. Neurology. 2026;107(7):e218499. doi:10.1212/WNL.0000000000218499
Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS
Dr. Zohaib Siddiqi and Dr. Michel Toledano discuss the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Show citation: Trentadue T, Martinez Sosa S, Itoh CY, et al. Clinical Reasoning: A 30-Year-Old Female Patient With Multiple Sclerosis Presenting With Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia. Neurology. 2025;105(12):e2
Optimizing Management of Episodic Cluster Headache
Dr. Tesha Monteith shares practical tips for improving outcomes for patients with episodic cluster headache.
Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine
Dr. Tesha Monteith discusses growing evidence supporting CGRP-targeted therapies as first-line preventive treatment options for people with migraine. Show citation: Reuter U, Dycke AV, Versijpt J, et al. Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial. Lancet Neurol. 2026;25(9):806-817. doi:10.1016/S1
Rethinking Seronegative NMOSD
Dr. Casey Kozak discusses why most patients referred with seronegative NMOSD ultimately receive alternative diagnoses, underscoring the challenges of accurate diagnosis in antibody-negative cases. Show citation: Lang MV, Welk GM, Tajfirouz DA, et al. Unveiling Misdiagnosis: Rethinking Seronegative NMOSD. Mult Scler. 2025;31(11):1381-1384. doi:10.1177/13524585251360648
The Menopause Transition and Epilepsy
Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation: Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650
The Menopause Transition and Epilepsy
Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation: Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650
TRUE-MOGAD Score
Dr. Casey Kozak discusses a new scoring system for MOGAD identification. Show citation: Vilaseca A, Filippatou AG, Said Y, et al. TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. Neurol Neuroimmunol Neuroinflamm. 2026;13(5):e200617. doi:10.1212/NXI.0000000000200617
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers
Dr. Hailey Katulski discusses limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers. Show citation: Başkurt K, Uyar GC, Yeşilbaş E, et al. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial). Int J Cancer. 2026;159(9):2300-2313. doi:10.1
Delusional Misidentification Syndromes - Part 9
In the final episode of this nine-part series, Dr. Christine Cliatt-Brown discusses pharmacologic and non-pharmacologic management.
Herpes Zoster Vaccination and Incident Dementia in Canada
Dr. Margarita Fedorova and Dr. Pascal Geldsetzer discuss how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia. Show citation: Pomirchy M, Chung S, Bommer C, Strobel S, Geldsetzer P. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. Lancet Neurol. 2026;25(2):170-180. doi:10.1016/S1474-4422(25)00
Understanding the Forces Shaping US Health Care
Dr. Jason Crowell and Dr. John McDonough discuss the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care. Show citation: Powell A. How to fix U.S. Healthcare? "Radical Action," says John McDonough. Harvard Gazette. August 18, 2026. Accessed August 20, 2026. https://news.harvard.edu/gazette/story/2
Delusional Misidentification Syndromes - Part 8
In the eighth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses delusional companion syndrome.
Delusional Misidentification Syndromes - Part 7
In the seventh episode of this nine-part series, Dr. Christine Cliatt-Brown discusses reduplicative paramnesia.
Delusional Misidentification Syndromes - Part 6
In the sixth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Cotard syndrome.
Prevalence of CTE at Death in National Football League Players
Dr. Shuvro Roy and Dr. Daniel Daneshvar discussed the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia. Show citation: Daneshvar DH, Nowinski CJ, Abdolmohammadi B, et al. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21. BMJ. 2026;394:e100
Clinical Manifestations of Primary CNS T-Cell Lymphoma
Dr. Kait Nevel and Dr. Katharina Schmidbauer discuss primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease. Show citation: Schmidbauer KJ, Karschnia P, Kaulen LD, et al. Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features. Neurol. 2
October 2026 President Spotlight: One AAN Community
In the October episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss updates on membership options that will help more neurology professionals connect with the AAN. Stay informed by watching the President's Spotlight video.
The Future of Child Neurology Residency Training - Part 2
In part two of this series, Dr. Dara Albert and Dr. Bruce Cohen highlight the most important takeaways from the task force findings. Show citation: Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.00000000002003
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 2
In the second episode of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim discuss key take-home messages from the guideline recommendations and share insights on integrating them into clinical practice. Show citation: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guideline
The Future of Child Neurology Residency Training - Part 1
In part one of this series, Dr. Dara Albert and Dr. Bruce Cohen discuss why the Child Neurology Society felt it was important to establish a task force to examine child neurology training at this point in time. Show citation: Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 1
In the first part of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim provide a brief overview of the guideline recommendations for pharmacologic treatment of migraine prevention in adults. Show citation: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommitte
Delusional Misidentification Syndromes - Part 5
In the fifth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses syndrome of subjective doubles.
Delusional Misidentification Syndromes - Part 4
In the fourth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses mirrored self-misidentification syndrome.
Delusional Misidentification Syndromes - Part 3
In the third episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Fregoli syndrome.
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Dr. Justin Abbatemarco and Dr. Irene Cortese discuss recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors. Show citation: Gonzalez CE, Fletcher A, Jenkins TL, et al. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. N Engl J Med. 2026;394(20):2061-
Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases
Dr. Kait Nevel and Drs. Ayal Aizer and Clara Baselga-Garriga discuss the link between primary motor cortex involvement in brain metastases and increased seizure risk. Show citation: Baselga-Garriga C, Purohit S, Lamba N, et al. Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases. Neurology. 2026;106(7):e214714. doi:10.1212/WNL.0000000000214714
Delusional Misidentification Syndromes - Part 2
In part two of this nine-part series, Dr. Christine Cliatt-Brown discusses Capgras syndrome.
Delusional Misidentification Syndromes - Part 1
In part one of this nine-part series, Dr. Christine Cliatt-Brown provides an overview of delusional misidentification syndromes.
Updates in Neuroinfectious Disease - Part 7
In the final episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the complex role of TNF alpha inhibition in tuberculosis treatment and the use of infliximab and other targeted therapies to manage inflammation.
September 7, 2026 Capitol Hill Report: BrainPAC
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from September 7th, discussing the busy month ahead for Congress, BrainPAC, and a couple of other advocacy news items. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 2
In part two of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss recommendations to help neurologists navigate the expanding landscape of myasthenia gravis treatments. Show citation: McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.000000000021
Bridging the Artificial Intelligence Training Gap - Part 2
In the second episode of this series, Dr. Justin Abbatemarco and Dr. Sara Marceglia discuss the risks of incorporating AI into clinical practice. Show citation: Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.
Updates in Neuroinfectious Disease - Part 6
In the sixth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss high-dose rifampin in TB meningitis.
Bridging the Artificial Intelligence Training Gap - Part 1
In part one of this series, Dr. Justin Abbatemarco and Dr. Alberto Priori discussed the use of artificial intelligence in neurology among peers, not just trainees. Show citation: Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026
September 2026 President Spotlight: Our Next Step in Brain Health
In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss BrainHealth.com and the AAN's expanding brain health movement. Stay informed by watching the President's Spotlight video.
Updates in Neuroinfectious Disease - Part 5
In the fifth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss dexamethasone and listeria meningitis.
Updates in Neuroinfectious Disease - Part 4
In the fourth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the use of dexamethasone in the treatment of pneumococcal meningitis.
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1
In the first installment of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss how emerging treatments for myasthenia gravis compare to one another. Show citation: McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351
National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care
Dr. Jason Crowell and Ka-Ho Wong discuss national trends in Medicare reimbursement for inpatient neurologic care. Show citation: Wong KH, Castillo M, King J, et al. National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023. Neurology. 2026;107(6):e218460. doi:10.1212/WNL.0000000000218460
Updates in Neuroinfectious Disease - Part 3
In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone.
Updates in Neuroinfectious Disease - Part 2
In part two of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss pegivirus-associated encephalomyelitis.
Updates in Neuroinfectious Disease - Part 1
In part one of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss acute necrotizing encephalopathy.
2026 Alzheimer's Association International Conference - Part 1
In part one of this series, Drs. Greg Cooper, Trey Bateman, and Gregg Day discussed key takeaways from the 2026 Alzheimer's Association International Conference, focusing on blood-based biomarkers, anti-amyloid therapies, and other important highlights.
Recap from the 2026 AAN Autoimmune Neurology Conference
Dr. Justin Abbatemarco recaps a presentation on Hashimoto encephalopathy from the AAN Autoimmune Neurology Conference. Show citation: Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021;3(2):fcaa233. Published 2021 Jan 5. doi:10.1093/braincomms/fcaa233 Brain, Jellinek E, Ball K HASHIMOTO'S
Lab Minute: Vitamin B12
In this lab minute, Dr. Stacey Clardy reviews the role of vitamin B12 testing in neurologic practice.
American Epilepsy Society Clinical Practice Guideline - Part 2
In part two of this series, Dr. Dara Albert and Dr. Daniel Freedman discuss key unanswered questions in infantile epilepsy and future research priorities. Show citation: Freedman D, Babatunde I, Morgan RL, et al. American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy. Epilepsy Curr. 2026;26(3):174-202. Published 2026 Apr 8. doi:10.1177/15357597261433266
The Relationship Between Age and Recovery After Spinal Cord Injury
Dr. Shuvro Roy and Prof. Catherine Jutzeler discussed how age influences neurologic and functional recovery after spinal cord injury and how these findings could inform treatment and future clinical trials. Show citation: Pavese C, Scivoletto G, Puci M, et al. The Relationship Between Age and Recovery After Spinal Cord Injury: A Longitudinal Cohort Study. Neurology. 2026;106(2):e214516. doi:10.1
Virtual vs In-Person Neurologic Ambulatory Care
Dr. Greg Cooper and Dr. Chloe Hill discuss comparing virtual and in-person neurology outpatient visits for new patients. Show citation: Hill CE, Lin CC, Harris A, et al. Virtual vs In-Person Neurologic Ambulatory Care: A Case-Control Study of Subsequent Health Care Utilization. Neurology. 2026;106(10):e214989. doi:10.1212/WNL.0000000000214989
Lab Minute: Tolosa Hunt Syndrome
In this lab minute, Dr. Stacey Clardy discusses Tolosa Hunt syndrome
Consortium of Neurology Residents and Fellows
Dr. Margarita Fedorova talks with Dr. Sunanjay Bajaj about the Consortium of Neurology Residents and Fellows (CNRF). Visit the AAN website to learn more about the CNRF. Connect with the AAN's Consortium of Neurology Residents and Fellows on Synapse.
Vamorolone for Duchenne Muscular Dystrophy
Dr. Aaron Zelikovich discusses the efficacy and anthropometric effect of vamorolone with prednisone and deflazacort. Show citation: Clemens PR, Berglund A, Schiava M, et al. Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial. Neurology. 2026;107(1):e214756. doi:10.1212/WNL.0000000000214756
American Epilepsy Society Clinical Practice Guideline - Part 1
In part one of this series, Dr. Dara Albert and Dr. Daniel Freedman share their key takeaways from the recent guideline. Show citation: Freedman D, Babatunde I, Morgan RL, et al. American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy. Epilepsy Curr. 2026;26(3):174-202. Published 2026 Apr 8. doi:10.1177/15357597261433266
Post-Traumatic Headache in Children and Genetic Risk of Migraine
Dr. Jessica Ailani and Dr. Serena Orr discuss the genetic risk of migraine and post-traumatic headache in children. Show citation: Orr SL, Hershey AD, Kurowski BG, et al. Post-Traumatic Headache in Children and Genetic Risk of Migraine: An Observational Cohort Study. Neurol Genet. 2026;12(2):e200371. Published 2026 Apr 1. doi:10.1212/NXG.0000000000200371
Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis
Dr. Aaron S. Zelikovich discusses the phase 3 NIMBLE trial of cemdisiran, an siRNA targeting complement component 5, for the treatment of generalized myasthenia gravis. Show citation: Vu T, Habib AA, Jacob S, et al. Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2026;407(10540):1712-1725. doi:10.1016/S
Negative Myoclonus
Dr. Zohaib Siddiqi shares clinical pearls on negative myoclonus.
An Update on Troriluzole
Dr. Margarita Fedorova discusses the use of troriluzole for spinocerebellar ataxia. Show citations: https://www.neurology.org/doi/10.1212/WNL.0000000000209018 https://clinicaltrials.gov/study/NCT06034886 https://clinicaltrials.gov/study/NCT02960893
The Current State of Diagnostics for Neuroimmunologic Disorders in Africa
Drs. Paul Crane, Fiifi Duodu, and Malya Sahu discuss neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care. Show citation: Sahu M, Chomba M, Duodu F, Diaz MM, Sokhi D, Saylor D. The Current State of Diagnostics for Neuroimmunological Disorders in Africa. J Cent Nerv Syst Dis. 2025;17:11795735251385319. Published 2025 Nov 19. doi:10.1177/1179
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
Dr. Elizabeth Coon and Dr. Lucy Norcliffe-Kaufmann discuss the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions. Show citation: Freeman R, Kaufmann H, Biaggioni I, et al. Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System
Sex Differences in Levodopa Pharmacokinetics in Early Parkinson Disease
Dr. Margarita Fedorova explores sex-related differences in the pharmacokinetics of levodopa among levodopa-naïve patients with PD and evaluates their relationships with levodopa-related complications. Show citation: Conti V, De Bellis E, Corbi G, et al. Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications. Front Pharmacol. 2026;
Psychiatric Comorbidities in Epilepsy - Part 2
In part two of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the steps to take if you are screening for a psychiatric comorbidity and the results indicate that someone may be positive for depression, anxiety, or another condition. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults
August 2026 President Spotlight: How We're Working with the AMA
In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost highlight how the AAN's growing representation within the AMA strengthens the voice of neurology. Stay informed by watching the President's Spotlight video.
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial.
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1
In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial.
Psychiatric Comorbidities in Epilepsy - Part 1
In part one of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the best methods for screening patients with epilepsy in a clinical setting. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia. 2022;63(2):316-334. doi:10.1111/epi.17140 Patel AD, Baca C, Frankli
2026 International Conference on Functional Neurological Disorder - Part 2
In the second episode of this series, Dr. Dara Albert and Dr. Jon Stone discuss the future of FND and the innovative topics presented at the conference.
Exploring Military Sexual Trauma and Migraine Among US Veterans - Part 2
In part two of this series, Dr. Stacey Clardy and Dr. John Ney discuss what neurologists should do differently after reading this article. Show citation: Ney J, Fenton B, Grinberg AS, et al. Association of Military Sexual Trauma With Migraine and Migraine-Related Health Care Utilization Among Post-9/11 US Veterans. Neurol Clin Pract. 2026;16(3):e200618. doi:10.1212/CPJ.0000000000200618
2026 International Conference on Functional Neurological Disorder - Part 1
In the first episode of this series, Dr. Dara Albert and Dr. Jon Stone emphasize the main takeaway from this year's conference that should be taught to residents.
Exploring Military Sexual Trauma and Migraine Among US Veterans - Part 1
In the first part of this series, Dr. Stacey Clardy and Dr. John Ney discuss the key clinical messages for all practicing neurologists. Show citation: Ney J, Fenton B, Grinberg AS, et al. Association of Military Sexual Trauma With Migraine and Migraine-Related Health Care Utilization Among Post-9/11 US Veterans. Neurol Clin Pract. 2026;16(3):e200618. doi:10.1212/CPJ.0000000000200618
Lab Minute: Susac Syndrome and Behçet Disease
In this lab minute, Dr. Stacey Clardy discusses Susac syndrome and Behçet disease.
Lab Minute: Human Prion Disease
In this lab minute, Dr. Stacey Clardy discusses human prion disease.
July 2026 President Spotlight: Mid-Year Update
In the July episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost provide a mid-year review of the AAN's progress, highlighting advocacy successes and the growing momentum for brain health worldwide. Stay informed by watching the President's Spotlight video.
Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants
Dr. Derek Stitt and Dr. Jennifer Morganroth discuss why identifying carrier status is so important. Show citation: Morganroth J, Yasek J, Harms M. Preparing Amyotrophic Lateral Sclerosis Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants. Neurol Genet. 2026;12(4):e200406. Published 2026 Jun 24. doi:10.1212/NXG.0000000000200406
When Drug Marketing Masquerades as Clinical Trials
Dr. Justin Abbatemarco and Sukhun Kang discuss seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care. Show citation: Kang S, Lin I, Ekblom M, and Chang S. Clinical trials that are actually marketing ploys targeting doctors – how seeding trials put profit over patients. The Conversation. 2026;6(5). doi:10.64628/AAI.cxdf
Recommended
پلی لیست | PlayList
Crime Stories with Nancy Grace
Conspiracy Files with Paige Carter
Bible Tea
Dark Night Tales with Brian King
Fox news
CBS Radio Mystery Theater | Old Time Radio
Old Time Radio Mystery, Suspense, & Horror
ABC News Update
Learn English Fast! English Snacks with Amber - Short Lessons to Speak English Like a Native
این نقطه
This Past Weekend w/ Theo Von
